Prostate Cancer - Results from #25100

Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon - Abstract August 14, 2012

Investigating the dosimetric and tumor control consequences of prostate seed loss and migration - Abstract August 14, 2012

Extended biopsy based criteria incorporating cumulative cancer length for predicting clinically insignificant prostate cancer - Abstract August 14, 2012

Long-term oncological outcomes after laparoscopic radical prostatectomy - Abstract August 14, 2012

Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of less than 2.5 ng/mL and the risk of death - Abstract August 14, 2012

Influence of opioid consumption on serum prostate-specific antigen levels in men without clinical evidence of prostate cancer - Abstract August 13, 2012

The effect of baseline testosterone on the efficacy of degarelix and leuprolide: Further insights from a 12-month, comparative, phase III study in prostate cancer patients - Abstract August 13, 2012

Diffusion tensor magnetic resonance tractography of the prostate: Feasibility for mapping periprostatic fibers - Abstract August 13, 2012

The impact of place and time on the proportion of late-stage diagnosis: The case of prostate cancer in Florida, 1981-2007 - Abstract August 13, 2012

Recovery of overall exercise ability, quality of life, and continence after 12-week combined exercise intervention in elderly patients who underwent radical prostatectomy: A randomized controlled study - Abstract August 13, 2012

Stamp test delivers message on erectile dysfunction after high-dose intensity-modulated radiotherapy for prostate cancer - Abstract August 13, 2012

Patented prostate cancer biomarkers - Abstract August 13, 2012

Chemotherapy for prostate cancer: When should a urologist refer a patient to a medical oncologist? - Abstract August 13, 2012

New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists - Abstract August 13, 2012

Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer - Abstract August 13, 2012

Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancer - Abstract August 13, 2012

Percutaneous MR-guided cryoablation of prostate cancer: Initial experience - Abstract August 13, 2012

Preliminary results of intensity-modulated radiation therapy with helical tomotherapy for prostate cancer - Abstract August 13, 2012

Primary androgen deprivation (AD) followed by active surveillance (AS) for newly diagnosed prostate cancer (PC): A retrospective study - Abstract August 13, 2012

Novel approaches in the pharmacotherapy of skeletal-related events in metastatic castrate-resistant prostate cancer - Abstract August 13, 2012

Page 1256 of 1434